About: Nyrada Inc., a clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia. Its lead candidate is Xolatryp, a small-molecule inhibitor targeting the transient receptor potential canonical ion channel subtypes 3, 6, and 7, which is in a Phase IIa clinical trial to treat myocardial ischemia, arrhythmia, stroke, and traumatic brain injury, as well as in a preclinical research stage for oncology indications. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.48 (-2.04%)
NYR ASX Nyrada Inc
Nyrada Inc share price
NYR price activity
Last Price
$0.480
Change (24hr)
-0.01 AUD (-2.04%)
Volume
287.87K
Volume (4w avg)
-
Open
$0.50
Day Range
$0.48 - $0.51
Previous Close
$0.49
Last Trade
09 Oct, 5:10 am GMT+0
Delayed
09 Oct, 5:10 am GMT+0
NYR price performance
Delayed
09 Oct, 5:10 am GMT+0
NYR Market Signals